-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: Continue the cooperation between the two sides in medical research, doctor-patient education and brand building since 2017.
, a company dedicated to providing disease management, online healthcare information, and professional medical training and education services to healthcare workers and the general public in China, yesterday announced the renewal of its contract with Johnson and Johnson (China) Co., Ltd. to continue to be a supplier and partner to Johnson and Johnson in China, continuing the cooperation between the two sides in medical research, doctor-patient education and brand building since 2017. Mr. Yang Weiguang, Chairman and Ceo of
Crowd Nest Medicine, commented: "As a Fortune 500 company and the world's largest pharmaceutical company (based on Fierce Pharma's 2019 revenue statistics), Johnson and Johnson has a number of research and development centers and production sites in China, and has developed and introduced a large number of medical devices and innovative pharmaceutical products in the Chinese market.
cites the example of Xi'an Yangsen, Johnson's Subsidiary in China, where 22 innovative products and indications were approved or listed in China in the 21 months to October 2020, covering the fields of psychiatry, haematology, solid tumors, immunology, infectious diseases, diabetes and pulmonary hypertension.
this series of innovative products and project promotions requires a large number of medical education content supporting the doctor-patient community, providing important business opportunities for suppliers and partners like Crowd Nest.
"China's healthcare market is still in its early stages of development, with a large business need for doctor education, patient education and disease management, and huge room for growth in the future.
Nest Medicine expects to continue to grow its business by working closely with leading pharmaceutical companies such as Johnson and Johnson to enable more of the world's leading medical technologies and innovative products to be popularized in the Chinese market and to promote the development of corresponding disciplines, ultimately benefiting patients and achieving the continued growth of the company's business.
, " Mr. Yang concluded.
.
